IONIS PHARMACEUT reported $219M in Operating Expenses for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Arrowhead Research ARWR:US $ 110.25M 19.49M
Astellas Pharma 4503:JP 317.56B 56.13B
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 137.27M 102.36M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Exelixis EXEL:US $ 272.74M 61.76M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Novartis NOVN:VX 10.96B 826M